Related Experiment Video
Updated: Apr 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Geographical distribution of Mycobacterium tuberculosis complex lineages in sub-Saharan Africa: an interactive review
J K Badiane1, Z Harouna Hamidou2, A Padane3
1IHU Méditerranée Infection, Marseille, France; Aix-Marseille-Université, MEPHI, IHU Méditerranée Infection, Marseille, France; Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Sénégal.
Abstract:
The capacity of the 49 sub-Saharan African countries, which account for 85% of tuberculosis cases in Africa (WHO, 2025), to monitor the genomic dynamics of Mycobacterium tuberculosis complex strains responsible for the disease was examined for the period 2000-2025. A total of 8141 GenBank entries, supplemented by 163 as yet unreported whole genome sequences prepared at the Institut Hospitalier-Universitaire, Marseille, France and the Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation, Dakar, Sénégal were analysed using TB-Profiler. M. tuberculosis sub-lineage L2.2.1 dominated the sub-continent, while other lineages and sub-lineages featured a discrete pattern of geographical distribution, here illustrated by interactive maps. Although three-quarters of the genomes showed a predicted antibiotic-susceptibility, the predicted resistant recovered in 80% countries largely comprised multidrug-resistant (MDR) genomes (12.19% of genomes), followed by Rifampicin-susceptible, isoniazid-resistant (HR-TB) genomes (4.47%), Rifampicin-resistant TB (RR-TB) genomes (3.31%), extensively drug-resistant (XDR) genomes (1.78%), and pre-XDR genomes (0.64%). Resistance to second-line antibiotics was observed with prevalence lower than that of first-line drugs. This review gives an updated, accurate, and interactive overview of tuberculosis in sub-Saharan Africa and provides a strong basis for following the current evolution of tuberculosis in African regions.
More Related Videos
Related Concept Videos
Bacterial Phylum Actinobacteria
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

